1. 017 Anti-Fibrotic Properties of RhoA Kinase-Inhibition in a Cell Culture Model of Peyronie's Disease. (1st July 2018) Authors: Milenkovic, U.; Ilg, M.M.; van Renterghem, K.; De Ridder, D.; Albersen, M. Journal: Journal of sexual medicine Issue: Volume 15(2018)Supplement 3 Page Start: S130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 022 Vardenafil and Tamoxifen Synergise in a Rat Model of Peyronie's Disease. (1st July 2018) Authors: Ilg, M.M.; Milenkovic, U.; Muneer, A.; Albersen, M.; Cellek, S.; Ralph, D.J. Journal: Journal of sexual medicine Issue: Volume 15(2018)Supplement 3 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 083 Critical Analysis of Human Amniotic Fluid as a Novel Biological Therapy. (1st April 2019) Authors: Campbell, J.; Sopko, N.A.; Milenkovic, U.; Talbot, C.C.; Zahalsky, M.; Dessources, G.; Albersen, M.; Bivalacqua, T.J. Journal: Journal of sexual medicine Issue: Volume 16(2019)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 277 Interplay Between TNFa and TGF-B1 in a Cell Culture Model of Peyronie's Disease. (1st July 2018) Authors: Milenkovic, U.; Ilg, M.M.; van Renterghem, K.; De Ridder, D.; Albersen, M. Journal: Journal of sexual medicine Issue: Volume 15(2018)Supplement 3 Page Start: S234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 386 Erectile Dysfunction in Peyronie's Disease is Independent of Cavernosal Inflammation and Fibrosis. (1st January 2020) Authors: Campbell, J.; Milenkovic, U.; Hawksworth, D.; Albersen, M.; Burnett, A.; Bivalacqua, T. Journal: Journal of sexual medicine Issue: Volume 17(2020)Supplement 1 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An update on emerging drugs for the treatment of erectile dysfunction. (2nd October 2018) Authors: Milenkovic, U.; Campbell, J.; Roussel, E.; Albersen, M. Journal: Expert opinion on emerging drugs Issue: Volume 23:Number 4(2018) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HP-01-001 Simvastatin and the Rho-kinase Inhibitor Y-27632 Prevent Myofibroblast Transformation in Peyronie's Disease-derived Fibroblasts via Inhibition of YAP/TAZ Nuclear Translocation. (1st May 2019) Authors: Milenkovic, U.; Ilg, M.; Zuccato, C.; Ramazani, Y.; De Ridder, D.; Albersen, M. Journal: Journal of sexual medicine Issue: Volume 16(2019)Supplement 2 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PS-04-004 Transcriptome-wide Analysis of Peyronie's Disease Plaques using RNA Sequencing Uncovers Targetable Signaling Pathways for Medical Therapy. (1st May 2019) Authors: Milenkovic, U.; Janky, R.; Hatzichristodoulou, G.; van Renterghem, K.; Cellek, S.; Bivalacqua, T.; De Ridder, D.; Albersen, M. Journal: Journal of sexual medicine Issue: Volume 16(2019)Supplement 2 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PS-3-5 Dendritic Cells and Cytotoxic T-Lymphocytes Driving the Inflammation in the Peyronie's Disease Micro-Environment. (1st June 2020) Authors: Milenkovic, U.; Boeckx, B.; van Renterghem, K.; Lambrechts, D.; Bivalacqua, T.; De Ridder, D.; Albersen, M. Journal: Journal of sexual medicine Issue: Volume 17(2020)Supplement 2 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗